Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low‐dose dexamethasone versus high‐dose dexamethasone in refractory or relapsed and refractory multiple myeloma

  1. Weisel, K.C.
  2. Dimopoulos, M.A.
  3. Moreau, P.
  4. Lacy, M.Q.
  5. Song, K.W.
  6. Delforge, M.
  7. Karlin, L.
  8. Goldschmidt, H.
  9. Banos, A.
  10. Oriol, A.
  11. Alegre, A.
  12. Chen, C.
  13. Cavo, M.
  14. Garderet, L.
  15. Ivanova, V.
  16. Martinez-Lopez, J.
  17. Knop, S.
  18. Yu, X.
  19. Hong, K.
  20. Sternas, L.
  21. Jacques, C.
  22. Zaki, M.H.
  23. Miguel, J.S.
Revue:
Haematologica

ISSN: 1592-8721,  0390-6078

Année de publication: 2016

Volumen: 101

Número: 7

Pages: 872-878

Type: Article

DOI: 10.3324/HAEMATOL.2015.137083 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus